Transcription factor decoys for activator protein-1 (AP-1) inhibit oxidative stress-induced proliferation and matrix metalloproteinases in rat cardiac fibroblasts

Translational Research

Volumn 153, Issue 1, 2009, Pages 17-23

  Xie, Shuanglun ^a   Nie, Ruqiong ^a   Wang, Jingfeng ^a   Li, Fei ^a   Yuan, Woliang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE B; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR AP 1; XANTHINE; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; FIBROBLAST; HEART MUSCLE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT;

EID: 57649087646     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2008.11.004     Document Type: Article

References (33)

1. Siwik D.A., Pagano P.J., and Colucci W.S. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 280 (2001) C53-C60
2. Fishbein M.C., Maclean D., and Maroko P.R. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90 (1978) 57-70
3. Byun J., Huh J.E., Park S.J., et al. Myocardial injury-induced fibroblast proliferation facilitates retroviral-mediated gene transfer to the rat heart in vivo. J Gene Med 2 (2000) 2-10
4. Sutton M.G., and Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101 (2000) 2981-2988
5. Weber K.T. Fibrosis and hypertensive heart disease. Curr Opin Cardiol 15 (2000) 264-272
6. Ahmed M.S., Oie E., Vinge L.E., et al. Connective tissue growth factor-a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats. J Mol Cell Cardiol 36 (2004) 393-404
7. Peterson J.T., Li H., Dillon L., and Bryant J.W. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc Res 46 (2000) 307-315
8. Bradham W.S., Moe G., Wendt K.A., et al. TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling. Am J Physiol Heart Circ Physiol 282 (2002) H1288-H1295
9. Siwik D.A., Chang D.L., and Colucci W.S. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86 (2000) 1259-1265
10. Cheng T.H., Cheng P.Y., Shih N.L., Chen I.B., Wang D.L., and Chen J.J. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J Am Coll Cardiol 42 (2003) 1845-1854
11. Sadoshima J., and Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73 (1993) 413-423
12. Tyagi S.C., Kumar S., and Borders S. Reduction-oxidation (redox) state regulation of extracellular matrix metalloproteinases and tissue inhibitors in cardiac normal and transformed fibroblast cells. J Cell Biochem 61 (1996) 139-151
13. Giordano F.J. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115 (2005) 500-508
14. Shao Z., Bhattacharya K., Hsich E., et al. c-Jun N-terminal kinases mediate reactivation of Akt and cardiomyocyte survival after hypoxic injury in vitro and in vivo. Circ Res 98 (2006) 111-118
15. Cook S.A., Sugden P.H., and Clerk A. Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. J Mol Cell Cardiol 31 (1999) 1429-1434
16. Zhang X., Azhar G., Nagano K., and Wei J.Y. Differential vulnerability to oxidative stress in rat cardiac myocytes versus fibroblasts. J Am Coll Cardiol 38 (2001) 2055-2062
17. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270 (1995) 16483-16486
18. Deschamps A.M., and Spinale F.G. Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation. Cardiovasc Res 69 (2006) 666-676
19. Ahn J.D., Morishita R., Kaneda Y., et al. Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo. Circ Res 90 (2002) 1325-1332
20. Villarreal F.J., Kim N.N., Ungab G.D., Printz M.P., and Dillmann W.H. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 88 (1993) 2849-2861
21. Morishita R., Gibbons G.H., Horiuchi M., Kaneda Y., Ogihara T., and Dzau V.J. Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site. Biochem Biophys Res Commun 243 (1998) 361-367
22. Ahn J.D., Morishita R., Kaneda Y., et al. Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells. Diabetologia 44 (2001) 713-720
23. Ahn J.D., Morishita R., Kaneda Y., et al. Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo. Gene Ther 11 (2004) 916-923
24. Burdon R.H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 18 (1995) 775-794
25. Sauer H., Wartenberg M., and Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11 (2001) 173-186
26. Cohn J.N., and Colucci W. Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology. Am J Cardiol 97 (2006) 4F-12F
27. Keith M., Geranmayegan A., Sole M.J., et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 31 (1998) 1352-1356
28. Li P.F., Dietz R., and von Harsdorf R. Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor-beta1 in cardiac fibroblasts. FEBS Lett 448 (1999) 206-210
29. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87 (2007) 1285-1342
30. Mukherjee R., Mingoia J.T., Bruce J.A., et al. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction. Am J Physiol Heart Circ Physiol 291 (2006) H2216-H2228
31. Sun Y., Zhang J.Q., Zhang J., and Lamparter S. Cardiac remodeling by fibrous tissue after infarction in rats. J Lab Clin Med 135 (2000) 316-323
32. Kelly D., Cockerill G., Ng L.L., et al. Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study. Eur Heart J 28 (2007) 711-718
33. Yarbrough W.M., Mukherjee R., Escobar G.P., et al. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling. Circulation 108 (2003) 1753-1759